Variant report
Variant | esv3366141 |
---|---|
Chromosome Location | chr21:41346258-41346543 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs577659908 | chr21:41346258-41346259 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
2 | rs142205519 | chr21:41346262-41346263 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
3 | rs541629412 | chr21:41346273-41346274 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
4 | rs561358094 | chr21:41346284-41346285 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
5 | rs368342847 | chr21:41346286-41346287 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
6 | rs62236606 | chr21:41346320-41346321 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
7 | rs543745461 | chr21:41346325-41346326 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
8 | rs575416049 | chr21:41346326-41346327 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
9 | rs563599140 | chr21:41346332-41346333 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
10 | rs113064071 | chr21:41346333-41346334 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
11 | rs80076341 | chr21:41346335-41346336 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
12 | rs28629236 | chr21:41346342-41346343 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
13 | rs78747515 | chr21:41346363-41346364 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
14 | rs62236607 | chr21:41346371-41346372 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
15 | rs531983651 | chr21:41346374-41346375 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
16 | rs551856561 | chr21:41346379-41346380 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
17 | rs565780227 | chr21:41346380-41346381 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
18 | rs113788440 | chr21:41346392-41346393 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
19 | rs111312418 | chr21:41346394-41346395 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
20 | rs62236608 | chr21:41346401-41346402 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs200068820 | chr21:41346421-41346422 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs374742055 | chr21:41346422-41346423 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs62236609 | chr21:41346430-41346431 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs113742828 | chr21:41346451-41346452 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs112447030 | chr21:41346453-41346454 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs9680352 | chr21:41346460-41346461 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs368707544 | chr21:41346481-41346482 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs372023757 | chr21:41346489-41346490 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs9680355 | chr21:41346510-41346511 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs13048892 | chr21:41346512-41346513 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs1734923 | chr21:41346519-41346520 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs377179961 | chr21:41346541-41346542 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Down syndrome | 17412756 | CNVD |
Down syndrome | 17576883 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Seminomas | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Prostate cancer | 19156837 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Melanoma | 18172304 | CNVD |
Autism | 22958593 | CNVD |
Schizophrenia | 22958593 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Wilms tumour | 21544195 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Mental retardation | 21031080 | CNVD |
Polymicrogyria | 21031080 | CNVD |
periventricular nodular heterotopia | 21031080 | CNVD |
Myelodysplastic syndrome | 21606161 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Autism | 18414403 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Breast cancer | 21858162 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 17899364 | CNVD |
Down syndrome | 20877625 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 20164920 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Prostate cancer | 21147910 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Prostate cancer | 17245344 | CNVD |
Prostate cancer | 20473283 | CNVD |
Chordoma | 18071362 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 21509527 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr21:41344400-41353000 | Weak transcription | Fetal Kidney | kidney |
2 | chr21:41344800-41346400 | Bivalent Enhancer | Fetal Muscle Leg | muscle |